These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


323 related items for PubMed ID: 28320856

  • 1. Sustained Reduction of Blood Pressure With Baroreceptor Activation Therapy: Results of the 6-Year Open Follow-Up.
    de Leeuw PW, Bisognano JD, Bakris GL, Nadim MK, Haller H, Kroon AA, DEBuT-HT and Rheos Trial Investigators.
    Hypertension; 2017 May; 69(5):836-843. PubMed ID: 28320856
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Novel baroreflex activation therapy in resistant hypertension: results of a European multi-center feasibility study.
    Scheffers IJ, Kroon AA, Schmidli J, Jordan J, Tordoir JJ, Mohaupt MG, Luft FC, Haller H, Menne J, Engeli S, Ceral J, Eckert S, Erglis A, Narkiewicz K, Philipp T, de Leeuw PW.
    J Am Coll Cardiol; 2010 Oct 05; 56(15):1254-8. PubMed ID: 20883933
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Baroreflex activation therapy lowers arterial pressure without apparent stimulation of the carotid bodies.
    Alnima T, Goedhart EJ, Seelen R, van der Grinten CP, de Leeuw PW, Kroon AA.
    Hypertension; 2015 Jun 05; 65(6):1217-22. PubMed ID: 25941348
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Baroreceptor stimulation for resistant hypertension: first implantation in France and literature review.
    Courand PY, Feugier P, Workineh S, Harbaoui B, Bricca G, Lantelme P.
    Arch Cardiovasc Dis; 2014 Dec 05; 107(12):690-6. PubMed ID: 25445751
    [Abstract] [Full Text] [Related]

  • 10. Renal responses to long-term carotid baroreflex activation therapy in patients with drug-resistant hypertension.
    Alnima T, de Leeuw PW, Tan FE, Kroon AA, Rheos Pivotal Trial Investigators.
    Hypertension; 2013 Jun 05; 61(6):1334-9. PubMed ID: 23589562
    [Abstract] [Full Text] [Related]

  • 11. Baroreflex activation therapy provides durable benefit in patients with resistant hypertension: results of long-term follow-up in the Rheos Pivotal Trial.
    Bakris GL, Nadim MK, Haller H, Lovett EG, Schafer JE, Bisognano JD.
    J Am Soc Hypertens; 2012 Jun 05; 6(2):152-8. PubMed ID: 22341199
    [Abstract] [Full Text] [Related]

  • 12. Electrical carotid baroreceptor stimulation.
    Schmidli J, von Allmen RS, Mohaupt MG.
    Wien Med Wochenschr; 2014 Dec 05; 164(23-24):508-14. PubMed ID: 25411011
    [Abstract] [Full Text] [Related]

  • 13. Blood pressure after blinded, randomized withdrawal, and resumption of baroreceptor-activating therapy.
    Beige J, Jentzsch T, Wendt R, Hennig G, Koziolek M, Wallbach M.
    J Hypertens; 2017 Jul 05; 35(7):1496-1501. PubMed ID: 28267039
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Resistant hypertension: baroreflex stimulation as a new tool.
    Menne J, Jordan J, Linnenweber-Held S, Haller H.
    Nephrol Dial Transplant; 2013 Feb 05; 28(2):288-95. PubMed ID: 23223217
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial.
    Bisognano JD, Bakris G, Nadim MK, Sanchez L, Kroon AA, Schafer J, de Leeuw PW, Sica DA.
    J Am Coll Cardiol; 2011 Aug 09; 58(7):765-73. PubMed ID: 21816315
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.